510(K) CLEARANCES 51 ▲2RECALLS POSTED 25 ▲2CLASS I 1PMA DECISIONS 50 ▲13WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K031606Substantially Equivalent

Access Immunoassay System Rubella Igg Assay

Siemens Healthcare Diagnostics Inc., Chaska MN / Special, Substantially Equivalent
FDA source (opens on fda.gov)510(k) summary (opens on fda.gov)

K031606 is the FDA 510(k) clearance record for ACCESS IMMUNOASSAY SYSTEM RUBELLA IGG ASSAY, a class II device, cleared for Beckman Coulter, Inc. on under FDA product code LFX (Enzyme Linked Immunoabsorbent Assay, Rubella). FDA records list 1,204 510(k) clearances for Siemens Healthcare Diagnostics Inc., from to . As of , FDA records show no recalls naming K031606.

Clearance record

Decision date
Received
(29 days to decision)
Product code
LFX Enzyme Linked Immunoabsorbent Assay, Rubella
Regulation
21 CFR 866.3510
Device class
Class II
Review panel
Microbiology
Applicant
Beckman Coulter, Inc. 1000 Lake Hazeltine Dr., Chaska MN
510(k) summary
Summary PDF
Third party review
No

Clearances, product code LFX

Trailing 12 months

FDA records hold no clearances under product code LFX in the trailing twelve months.

FDA records show no clearances under product code LFX in the twelve months to November 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code LFX, trailing twelve months
MonthClearances
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260
November 20260